Drug intelligence / Profile preview

TRTP-20X

Development stage: Preclinical
Lead developer: CellinCells
Modality: Cell Therapies, Drug Delivery Systems
Administration: Topical, Subcutaneous

Overview

TRTP-20X is an investigational organelle-based therapeutic candidate developed by Cell In Cells, utilizing their proprietary Tissue-specific Retrograde Transport Platform (TRTP). This platform is designed to facilitate the delivery of functional organelles, specifically mitochondria, into target cells to address conditions characterized by mitochondrial dysfunction or cellular senescence. TRTP-20X is currently being developed for dermatological and aesthetic indications, including skin rejuvenation and the treatment of alopecia (hair loss). By delivering healthy mitochondria, the therapy aims to restore ATP production, reduce oxidative stress, and stimulate regenerative pathways in the skin and hair follicles.

Beyond the preview

Go deeper on TRTP-20X.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRTP-20X.

Explore the full profile